InnoCare Optoelectronics Corporation (TPE:6861)
Taiwan · Delayed Price · Currency is TWD 65.60
-0.20 (-0.30%)
Jan 22, 2026, 1:35 PM CST
InnoCare Optoelectronics Revenue
InnoCare Optoelectronics had revenue of 554.84M TWD in the quarter ending September 30, 2025, with 14.70% growth. This brings the company's revenue in the last twelve months to 2.18B, up 11.40% year-over-year. In the year 2024, InnoCare Optoelectronics had annual revenue of 1.99B with 8.30% growth.
Revenue (ttm)
2.18B
Revenue Growth
+11.40%
P/S Ratio
1.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.99B | 152.55M | 8.30% |
| Dec 31, 2023 | 1.84B | -49.50M | -2.62% |
| Dec 31, 2022 | 1.89B | -54.14M | -2.79% |
| Dec 31, 2021 | 1.94B | -394.57M | -16.90% |
| Dec 31, 2020 | 2.34B | 1.90B | 439.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |